openPR Logo
Press release

Self-assembling Vaccines Market is Driven by Significant Investments in the Development of Self-assembling Vaccines for Coronavirus

10-16-2020 08:44 AM CET | Health & Medicine

Press release from: Transparency Market Research

Self-assembling Vaccines Market is Driven by Significant

Self-assembling Vaccines: Introduction

Vaccines are one of the major and effective interventions that help prevent spread for diseases. These help in reducing infectious diseases and save millions of lives globally each year.

Increase in understanding of self-assembly of viral proteins and virus-like particles (VLPs) has opened new opportunities in the development of chimeric VLPs, displaying heterologous epitopes attached to VLPs. Epitopes can be attached by covalent modification or through genetic engineering.

Read Report Overview - https://www.transparencymarketresearch.com/selfassembling-vaccines-market.html

Self-assembling vaccines, such as VaxCelerate, were developed by rapidly generating and performing pre-clinically testing a vaccine against a particular pathogen. Mixing MAV strain with biotinylated pathogen specific immunogenic peptides yields a self-assembled vaccine.

Key Drivers and Restraints of Global Self-assembling Vaccines Market

The global self-assembling vaccines market is primarily driven by significant investments in the development of self-assembling vaccines for coronavirus and increase in number of academic & research institutes studying vaccine usage for coronavirus

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77186

Increase in government support for vaccine development, rise in efforts toward research & development of novel vaccines, and high prevalence of infectious diseases are projected to drive the global market during the forecast period
In March 2020, Ufovax, a spin-off vaccine company from Scripps Research, announced extension of patented self-assembling protein nanoparticle vaccine platform technology to develop a vaccine against the coronavirus SARS-CoV-2
Respiratory Diseases Segment to Account for Major Share of Global Self-assembling Vaccines Market

In terms of indication, the global self-assembling vaccines market can be classified into respiratory diseases, infectious diseases, cancer, and others
The respiratory diseases segment is anticipated to dominate the global market during the forecast period, due to increase in the number of research studies determining the use of self-assembling vaccines for COVID-19 and rise in awareness about new therapies for treatment of respiratory infections
A number of companies are collaborating with academic & research institutes and other pharmaceutical companies for the development of self-assembling vaccines for COVID-19

In March 2020, Hoth Therapeutics entered into an agreement with Voltron Therapeutics to form a joint venture entity, “HaloVax”, to begin preclinical trials for the development of vaccine for prevention of COVID-19, which is based on VaxCelerate. VaxCelerate, a self-assembling vaccine, is exclusively licensed by Voltron from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH).

Request for Analysis of COVID-19 Impact on Self-assembling Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77186

Academic & Research Institutes Segment to Capture Major Share of Global Market

Based on end-user, the global self-assembling vaccines market can be categorized into hospitals & clinics, ambulatory surgical centers, academic & research institutes, and others

The academic & research institutes segment is expected to account for major share of the global self-assembling vaccines market by 2027. This is attributed to increase in efforts toward development of self-assembling vaccines, rise in availability of necessary infrastructure for research, and presence on qualified & experienced research professionals.

North America to Dominate Global Self-assembling Vaccines Market

In terms of region, the global self-assembling vaccines market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global self-assembling vaccines market during the forecast period.

The market in North America is anticipated to be driven by increase in burden of COVID-19, rise in support from the U.S. Government for vaccine development, and large number of companies signing strategic agreements and entering into partnerships with other prominent players for vaccine co-development

Pre Book Self-assembling Vaccines Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77186<ype=S

Key Players Operating in Global Self-assembling Vaccines Market

The global self-assembling vaccines market is highly fragmented, with a large number of domestic players accounting for major market share. Key players operating in the global self-assembling vaccines market are:

Argos Therapeutics, Inc.
Icosavax, Inc.
Hoth Therapeutics
Voltron Therapeutics

More Trending Reports by Transparency Market Research –

Asthma Treatment Market: https://www.biospace.com/article/asthma-treatment-market-increasing-penetration-of-generic-drugs-to-drive-sluggish-growth/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Self-assembling Vaccines Market is Driven by Significant Investments in the Development of Self-assembling Vaccines for Coronavirus here

News-ID: 2161570 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion